rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Venus Remedies Ltd.

526953 VENUSREM Group (B)

26 Jul,15:52
407.85
12.30 (3.11%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Venus Remedies Ltd.

BUYSELL

5,145 395.55 409.95 - 400.00 429.60 - 222.00 546.52
NSE | BSE

Venus Remedies Ltd.

VENUSREM

26 Jul,15:46
408.95
12.70 (3.21%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Venus Remedies Ltd.

BUYSELL

124,222 396.25 410.00 - 397.60 430.00 - 222.00 50,480,094.14

News for Venus Remedies Ltd.

Crocs Launches 'Splash Your Style' Campaign for Gen Z
Crocs unveils a monsoon campaign featuring its iconic clogs and Jibbitz charms, targeting India's Gen Z with a focus on self-expression through dance.
Jun 20, 2024 17:43
Venus Remedies...
Venus Remedies Gets Oncology Drug Approvals in Philippines, Saudi Arabia
Venus Remedies has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs, expanding its reach in Southeast Asia and the Middle East.
Dec 06, 2023 12:18

More News for Venus Remedies Ltd. »

(Rs. Crore)

Financial Results of Venus Remedies Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales575.21537.66575.18514.62322.36
Operating profit60.8861.5368.8246.8643.07
Interest---12.7313.05
Gross profit72.2071.7077.2551.9033.60
EPS (Rs)22.8221.6636.6543.97-6.67

See more in Research Center »

News for Pharmaceuticals and health care

Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05
Kargil Vijay...
Kargil Vijay Diwas: India Post Releases Commemorative Stamp
India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.
Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax...
G20 Agrees to Tax Super-Rich, Brazil Leads Effort
Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...
Jul 27, 2024 03:35
Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios
17.87
EPS (Rs.)
22.82
Sales (Rs. Cr)
175.16
Face Value (Rs.)
10
Net Profit Margin (%)
5.38
Last Bonus
Last Dividend(%)
30
Return on Average Equity
6.05

Compare 'Venus Remedies Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Most Active

  • Change (Rs.)
  •  

Venus Remedies Ltd. performance snapshot

If you had invested Rs.  in Venus Remedies Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Venus Remedies Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Venus Remedies Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close